CIK: 1077980 - Address: Scolr Pharma, Inc., 19204 N. Creek Parkway, Suite 100, Bothell, WA 98011
4 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret114-01-44-20-41-10
P%wins5075505025042

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/2/08 13:11
5/30/08
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLevy Richard MWAOCFOP51.10552228I-55-55-49-37-40642-15433-18-25
12/12/07 16:00
12/10/07
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLevy Richard MWAOCFOP.dm51.23542223I-1314-23-20-25-11-6-623-10-15-33-46
12/7/07 13:41
12/6/07
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLevy Richard MWAOCFOP.m51.34542719I-416-12-12-17-8020-9-21-27-44-66
3/16/07 15:28
3/16/07
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLevy Richard MWAOCFOP332.25415New15I0-201429-5-7-10-3-23122415-27

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact